Literature DB >> 21288840

Reaching MDG 4 in India: a role for rotavirus vaccine?

Edmund Anthony S Nelson, Damian G Walker.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21288840     DOI： 10.1093/cid/ciq095

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

2.  Direct costs of hospitalization for rotavirus gastroenteritis in different health facilities in India.

Authors:  T V Sowmyanarayanan; Tushar Patel; Rajiv Sarkar; Shobha Broor; Shobha D Chitambar; Triveni Krishnan; Rashmi Arora; Gagandeep Kang
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.